Kontrol BioCloud - a Safe Space Technology™

COVID-19 Detection Technology Receives Positive Lab Results for Live COVID-19 Testing

Free
Message: Kontrol Technologies Expands BioCloud Global Footprint

Adds customers in Australia France Belgium Turkey , and Germany .
Releases Software Update.

TORONTO Sept. 7, 2021 /PRNewswire/ - Kontrol Technologies Corp. (KNR: NEO) (KNRLF: OTCQB) (" Kontrol " or the " Company "), a leader in smart building technology, is expanding its BioCloud technology to new customers in Australia , France , Belgium , Turkey and Germany .

"Real-time air quality monitoring and the need to create safer spaces has never been more important in order to get back to normal across the global economy," said Paul Ghezzi , CEO of Kontrol. "Innovation is at the heart of our business, and we are pleased to expand the use of our unique air quality technology by entering additional markets with new customers. We continue to enhance BioCloud through ongoing software updates and expanded applications. We are pleased with our updated independent lab testing and we will continue to focus on growing our IP moat by expanding our patent portfolio to create long-term value for our stakeholders. "

Software Update

Kontrol BioCloud has released its new software update focused on an improved graphical user interface, enhancements to data logging, data exporting and more. Software releases are planned for up to three times per year with continuous enhancements and new features based on customer feedback.

Independent Lab Testing

As previously announced, Kontrol is providing an update on its independent lab testing and performance results, of which the Company is pleased with the status.  A summarized copy can be found at www.kontrolbiocloud.com/research .  The full report is provided to various Government entities and potential significant customers under Non-Disclosure Agreement.

Technology Extension

The Company has submitted an application for Government funding for Research and Development relating to an extension of the BioCloud technology for real-time sampling and early viral detection in critical water infrastructure. The Company has initiated a prototype application based on the existing architecture of the Kontrol BioCloud technology.

There are numerous applications for the BioCloud technology we are reviewing as part of ongoing research and development, including water infrastructure and agricultural," said Gary Saunders , President of Kontrol BioCloud. "We are reviewing each of these carefully and will seek Government funding as may be available to support applicable Research and Development."

About Kontrol BioCloud TM

Kontrol BioCloud is an operating subsidiary of Canadian public company Kontrol Technologies. The BioCloud technology is a real-time analyzer designed to detect airborne viruses and pathogens. BioCloud is an air quality technology and not a medical device. BioCloud has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and a silent notification system is created. BioCloud can be applied to any space where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

Kontrol Technologies Corp.

Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Share
New Message
Please login to post a reply